Loading asset research
Citius Pharmaceuticals Inc. Common Stock
CTXRNasdaq · USD · StocksQuote as of · Exchange session not verified$0.581
-0.68%
Today
CTXR
Loading 1D prices…
Market cap
$15.9M
Volume
153.8K
52w high
$2.1952w low
$0.469Company profile
Citius Pharmaceuticals Inc. Common Stock
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Cranford, NJ, United States
Employees
23
Fiscal year end
0930
CIK
1506251
Session & valuation
Open$0.586
Previous close$0.585
Day high$0.595
Day low$0.581
30-day avg. volume747.1K
Outstanding shares27.5M
Diluted EPS-$1.64
Latest annual period
P/E (trailing)-0.35
P/E (forward)-0.40
Price / book0.24
Beta1.00
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| RKTORocket One Inc. Common Stock | $15.9M | $0.00 | — | -$0.90 | -0.62% | Buy |
| CYCNCyclerion Therapeutics Inc. Common Stock | $15.7M | $2.1M | -170.11% | -$1.11 | -19.53% | Unrated |
| AEONAEON Biopharma Inc. Class A Common Stock | $16.3M | $0.00 | — | -$3.95 | +12.76% | Buy |
| BIVIBioVie Inc. Class A Common Stock | $16.3M | $0.00 | — | -$3.05 | +1.05% | Unrated |
| GTBPGT Biopharma Inc. Common Stock | $15.5M | $0.00 | — | -$6.68 | +39.32% | Buy |